Sodium Fluoride F-18

氟化钠（F18）

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameSodium Fluoride F-18
Drug Alias Name18-F Sodium Fluoride18F-NaFIASOflu
ClassificationSmall moleculesRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Nuclides > Fluorine > 18F
Mechanisms of ActionUndefined mechanism
TargetsNot applicable
Therapy Area/IndicationsBone metastasesContrast agentsIschemic Stroke +[8] 
Global Approved IndicationsBone metastasesContrast agents
Approved Indications in ChinaBone metastasesContrast agents
Original Approved Country/TerritoryFrance
Original Approved Date2008/01/01
Country/TerritoryCanadaUnited StatesNetherlands +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesAdvanced Accelerator Applications Sa
China Registration ClassN/A

Develop Information

Active CompaniesAnahuac Mayab UniversityAtlantic Health System IncHta Co Ltd
Inactive CompaniesCanadian Institutes Of Health Research (Cihr)Maastricht University Medical CenterNational Cancer Institute +[4] 
Active IndicationsBone metastasesContrast agentsIschemic Stroke +[5] 
Inactive IndicationsAortic Valve StenosisProstatic NeoplasmsBreast Neoplasms

Other Information

ATC CodeV09IX06
Related LinksN/A